These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11568421)

  • 1. The ability to orient attention in Gilles de la Tourette syndrome.
    Howells D; Georgiou-Karistianis N; Bradshaw J
    Behav Neurol; 1998; 11(4):205-209. PubMed ID: 11568421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed attention in Gilles de la Tourette syndrome.
    Georgiou N; Bradshaw JL; Phillips JG
    Behav Neurol; 1998; 11(2):85-91. PubMed ID: 11568405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reorientation of attention in Huntington disease.
    Georgiou-Karistianis N; Churchyard A; Chiu E; Bradshaw JL
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Dec; 15(4):225-31. PubMed ID: 12464749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orienting attention in obsessive-compulsive disorder.
    Georgiou-Karistianis N; Howells D; Bradshaw J
    Cogn Behav Neurol; 2003 Mar; 16(1):68-74. PubMed ID: 14765003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced habit formation in Gilles de la Tourette syndrome.
    Delorme C; Salvador A; Valabrègue R; Roze E; Palminteri S; Vidailhet M; de Wit S; Robbins T; Hartmann A; Worbe Y
    Brain; 2016 Feb; 139(Pt 2):605-15. PubMed ID: 26490329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Huntington's disease and Gilles de la Tourette's syndrome on the ability to hold and shift attention.
    Georgiou N; Bradshaw JL; Phillips JG; Chiu E
    Neuropsychologia; 1996 Sep; 34(9):843-51. PubMed ID: 8822731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.
    Robertson MM; Cavanna AE
    Psychiatr Genet; 2007 Jun; 17(3):143-52. PubMed ID: 17417057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome.
    Worbe Y; Marrakchi-Kacem L; Lecomte S; Valabregue R; Poupon F; Guevara P; Tucholka A; Mangin JF; Vidailhet M; Lehericy S; Hartmann A; Poupon C
    Brain; 2015 Feb; 138(Pt 2):472-82. PubMed ID: 25392196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Event-related brain potentials show changed attentional mechanisms in Gilles de la Tourette Syndrome.
    Johannes S; Weber A; Müller-Vahl KR; Kolbe H; Dengler R; Münte TF
    Eur J Neurol; 1997 Mar; 4(2):152-61. PubMed ID: 24283908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Movement lateralization and bimanual coordination in children with Tourette syndrome.
    Avanzino L; Martino D; Bove M; De Grandis E; Tacchino A; Pelosin E; Mirabelli M; Veneselli E; Abbruzzese G
    Mov Disord; 2011 Sep; 26(11):2114-8. PubMed ID: 21932301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three Cases of Palatal Tics and Gilles De La Tourette Syndrome.
    Rizzo R; Cath D; Pavone P; Tijssen M; Robertson MM
    J Child Neurol; 2015 Aug; 30(9):1199-203. PubMed ID: 25246300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gilles de la Tourette syndrome and disruptive behavior disorders: prevalence, associations, and explanation of the relationships.
    Robertson MM; Cavanna AE; Eapen V
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):33-41. PubMed ID: 25162416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome.
    Heise KF; Steven B; Liuzzi G; Thomalla G; Jonas M; Müller-Vahl K; Sauseng P; Münchau A; Gerloff C; Hummel FC
    Brain; 2010 Feb; 133(Pt 2):580-90. PubMed ID: 20008030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
    Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
    Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gilles de la Tourette: The history of the man and his illness; a medical historical study].
    Gilson F
    Tijdschr Psychiatr; 2012; 54(7):427-36. PubMed ID: 22811054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tics: from Itard to the neuroleptics].
    Dugas M
    Rev Neurol (Paris); 1986; 142(11):817-23. PubMed ID: 3547547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convulsive tic disorder georges gilles de la tourette, guinon and grasset on the phenomenology and psychopathology of gilles de la tourette syndrome.
    Robertson MM; Reinstein DZ
    Behav Neurol; 1991; 4(1):29-56. PubMed ID: 24487352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in patients with Gilles de la Tourette syndrome at the transition between adolescence and adulthood.
    Silvestri PR; Chiarotti F; Baglioni V; Neri V; Cardona F; Cavanna AE
    Neurol Sci; 2016 Nov; 37(11):1857-1860. PubMed ID: 27457656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.
    Kanaan AS; Gerasch S; García-García I; Lampe L; Pampel A; Anwander A; Near J; Möller HE; Müller-Vahl K
    Brain; 2017 Jan; 140(1):218-234. PubMed ID: 28007998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gilles de la Tourette syndrome is not linked to D2-dopamine receptor.
    Gelernter J; Pakstis AJ; Pauls DL; Kurlan R; Gancher ST; Civelli O; Grandy D; Kidd KK
    Arch Gen Psychiatry; 1990 Nov; 47(11):1073-7. PubMed ID: 1978653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.